PARAPROTEINEMIC POLYNEUROPATHY ASSOCIATED WITH MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE: СLINICAL CASE DESCRIPTION AND LITERATURE REVIEW

Monoclonal gammopathy of undetermined significance represents a number of conditions, the development of which is based on functional impairment of B-lymphocytes, which results in permanent pathological secretion of a single clone of immunoglobulins or their constituent chains. One of the leading and often the only clinical manifestation of monoclonal gammopathy is peripheral neuropathy associated with paraproteinemia. The article presents a clinical case of severe peripheral neuropathy associated with monoclonal gammopathy of undetermined significance. The diagnosis was confirmed on the basis of a comprehensive diagnosis, including screening paraproteinemic proteins in serum and a single urine sample is a method of immunofixation. Polyneuropathy was treated by using intravenous human immunoglobulin, as well as non-drug methods of rehabilitation (local cryotherapy, physical therapy and stabilometry). The therapy made a positive effect in reducing the symptoms, primarily the sensory and neuropathic components and polyneuropathy.

1. Ginsberg M.A., Varlamova E.Y., Ryzhko V.V., Suponeva N.А., Piradov M.A. Clinical and neurophysiological studies of chronic demyelinating polyneuropathy associated with monoclonal secretion // Medical Council. – 2015. – №10. – С. 93-99 (In Russian).

2. Levin O.S. Polyneuropathies: clinical guidelines. – 2nd edition. – М., 2006. – 486 p. (In Russian).

3. Landgren O., Kyle R.A., Pfeiffer R.M. et al. Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study // Blood. – 2009. – Vol. 113. – №22. – P. 5412-5415.

4. Belyakov K.M., Gustov A.V. Paraneoplastic polyneuropathies. – Nizhnii Novgorod: NizhGMA press, 2007. – 96 p. (In Russian).

5. Dispenziery, A. Peripheral blood stem cell transplantation in 16 patiens with POEMS syndrome and revive of literature // Blood. – 2004. – Vol. 104. – №10. – P. 3400-3407.

6. Larue, S., Bombelli, F., Viala, K., Neil, J., Maisonobe, T., Bouche, P., Musset, L., Fournier, E., Léger, J. M. Non-antiMAG DADS neuropathy as a variant of CIDP: clinical, electrophysiological, laboratory features and response to treatment in 10 cases // Eur. J. Neurol. – 2011. – Vol. 18. – P. 899–905.

7. Mata, S., Borsini, W., Ambrosini, S., Toscani, L., Barilaro, A., Piacentini, S., Sorbi, S., Lolli, F. IgM monoclonal gammopathyassociated neuropathies with different IgM specificity // Eur. J. Neurol. – 2011. – Vol. 18. – P. 167–173.

8. Pestronk, A., Florence, J., Miller, T., Choksi, R., AlLozi, M.T., Levine, T.D. Treatment of IgM antibody associated polyneuropathies using rituximab // J. Neurol. Neurosurg. Psychiatry. – 2003. – Vol. 74. – P. 485–489.

9. Suponeva N.A., Nikitin S. Chronic polyneuropathies assotiated with monoclonal gammapathies // Doctor. Moscow: Publ. house «Russian doctor». – 2010. – Vol. 9. – P. 51-54 (In Russian).

10. Rosenberg N., Portegies P., de Visser M. et al. Diagnostic investigation of patients with chronic polyneuropathy: evaluation of a clinical guideline // J. Neurol. Neurosur. Psychiat. – 2001. – Vol. 71. – P. 205–209.

11. Young M.J., Boulton A.J.M., Macleod A.F. et al. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population // Diabetologia. – 1993. – Vol. 36. – P. 150–154.

12. Backonja, M-M., Krause, S.J. Neuropathic Pain Questionnaire Short Form // Clin J Pain. – 2003. – Vol. 19. – P. 315 – 316.

13. Freynhagen R., Baron R., Gockel U., Tolle T. Pain detect: a new screening questionnaire to detect neropathic components in patients with back pain // Curr Med Res Opin. – 2006. – Vol. 22. – P. 1911-20.

14. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group // Br J Haematol. – 2003. – Vol. 121. – №5. – P. 749-757.

15. Moiseev S.I., Salogub G.N., Stepanova N.V. Modern principles od diagnostic and treatment of multiple myeloma. – SPb: SPbGMU, 2006. – 39 p. (In Russian).

16. Suponeva N.A., Pavlov E.V. Diagnostics and basic treatment of chronicpolyneuropathies // Doctor. – 2009. – №4. – P. 43–44 (In Russian).

17. Hadden R., Hughes R. Management of inflammatory neuropathies // J. Neurol. Neurosur. and Psychiat. – 2003. – Vol. 74. – P. 9–14.

18. Radl J., Valentijn R.M., Haaijman J.J., Paul L.C.Monoclonal gammapathies in patients undergoing immunosuppressive treatment after renal transplantation // Clin Immunol Immunopathol. – 1985. – Vol. 37. – №1. – P. 98-102.

19. Gahrton G., Durie B., Samson D. Multiple myeloma and related disorders. – London: Arnold, 2004. – 465 p.

20. Gorson K.C, Allam G., Ropper A.H. Chronic inflammatory demyelinating polyneuropathy: clinical features and response to treatment in 67 consecutive patients with and without a monoclonal gammopathy // Neurology. – 1997. – Vol. 48. – №2. – P. 321-328.

21. Kyle R.A. Monoclonal gammopathy of undetermined significance: natural history in 241 cases //Am J Med. –1978. – Vol. 64. – P. 814–26.

22. Glavey S.V., Leung N. Monoclonal gammopathy: The good, the bad and the ugly // Blood Reviews. – 2016. – Vol. 30. – P. 223-231.

23. Schmidt E.B., Moller-Petersen J. Monoclonal Gammopathy in General Practice Diagnostic Value of Typing and Quantitation of Immunoglobulins // Scandinavian Journal of Primary Health Care. – 1985. – Vol. 3. – №2. – P. 91-94.

24. Rison R.A., Beydoun S.R. Paraproteinemic polyneuropathy: a practical review //BMC Neurology. – 2016. – Vol. 16. – №13. – P. 1-14.

25. Farhad K., Traub R., Ruzhansky K.R. et al. Causes of Neuropathy in Patients Referred as «Idiopathic Neuropathy» // Muscle Nerve. – 2016. – Vol. 53. – P. 856-861.

26. Gesquiere-Dando A., Delmont E., Launay M. et al. Are electropsysiological features related to disability in patients with anti-MAG neuropathy? // Clinical Neurophysiology. – 2017. – Vol. 47. – P. 75-81.

27. Strokov I.A., DyukovaC.M.,Pogromov A.P. et al. Familial amyloid neuropathy associated with the Cys 114 mutation of the transthyretin gene in a Russian family // Journal of neurology and psychiatry named after S.S. Korsakov. – 2007. – №9. – P.67-72 (In Russian).

28. Leevy C., Dudeja P., Tyagi S., Kavilaveettil R. J. et al. Mechanism of thiamine uptake by human jejunal brushborder membrane vesicles // Am. J. Physiol. Cell Physiol. – 2001. – Vol. 281. – №3. – P. 786–792.

29. Muley S., Parry G. Inflammatory demyelinating neuropathies // Curr Treat Options Neurol. – 2009. – Vol. 11. – №3. – P. 221–227.